{
    "eid": "2-s2.0-85133954126",
    "title": "Disparities in Access to Systemic Treatment for Breast Cancer in Thailand and Major Asian Territories",
    "cover-date": "2022-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "Antineoplastic Agents",
        "Asians",
        "Breast Neoplasms",
        "Healthcare Disparity",
        "Thailand"
    ],
    "authors": [
        "Suthinee Ithimakin",
        "Napa Parinyanitikul",
        "Sung Bae Kim",
        "Yoon Sim Yap",
        "Janice Tsang",
        "Inda S. Soong",
        "Yukinori Ozaki",
        "Shinji Ohno",
        "Makiko Ono",
        "Jack Junjie Chan",
        "Hung Chun Skye Cheng",
        "Thitiya Dejthevaporn"
    ],
    "citedby-count": 2,
    "ref-count": 20,
    "ref-list": [
        "Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries",
        "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries",
        "The global cancer divide: relationships between national healthcare resources and cancer outcomes in high-income vs. middle-and low-income countries",
        "A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)",
        "ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe",
        "Cancer medicines in Asia and Asia-Pacific: what is available, and is it effective enough?",
        "Breast cancer in Thailand: policy and health system challenges to universal healthcare",
        "Enhancing global access to cancer medicines",
        "Approaches to improving access to essential cancer medicines in the WHO South-East Asia Region",
        "The economic impact of the transition from branded to generic oncology drugs",
        "Clinical significance of the 21-gene signature (Oncotype DX) in hormone receptor-positive early stage primary breast cancer in the Japanese population",
        "Distribution of 21-gene recurrence scores among breast cancer histologic subtypes",
        "Validation of the 18-gene classifier as a prognostic biomarker of distant metastasis in breast cancer",
        "A preliminary report of head-to-head comparison of 18-gene-based clinical-genomic model and oncotype DX 21-gene assay for predicting recurrence of early-stage breast cancer"
    ],
    "affiliation": [
        {
            "affiliation-city": "Tokyo",
            "@id": "60032495",
            "affilname": "Cancer Institute Hospital of Japan Foundation for Cancer Research",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032495",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hong Kong",
            "@id": "60081583",
            "affilname": "Hong Kong Hospital Authority",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60081583",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Taipei",
            "@id": "60032738",
            "affilname": "Koo Foundation Sun Yat-Sen Cancer Center Taiwan",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032738",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "60031809",
            "affilname": "National Cancer Centre, Singapore",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031809",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Hong Kong",
            "@id": "60006541",
            "affilname": "The University of Hong Kong",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006541",
            "affiliation-country": "Hong Kong"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60006240",
            "affilname": "University of Ulsan College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006240",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Taitung",
            "@id": "100802051",
            "affilname": "Taitung Christian Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100802051",
            "affiliation-country": "Taiwan"
        }
    ],
    "funding": [
        "Eisai and Taiho",
        "OBI Pharma",
        "Novartis",
        "Sanofi-Aventis"
    ]
}